The filing is a routine tax-withholding sale by an officer following a restricted stock vesting. No material insider signal; monitor the company's next earnings release for any fundamental changes.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5- T+0 · Nov 3 $140.30entry
- T+1 · 13d ago +1.63%α −0.03% · $142.58
- T+5 · 7d ago −5.82%α −5.24% · $132.13
- T+9 · todayOpen
- T+20 · in 15d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Robert F. Werner, an officer of Twist Bioscience, filed a Form 144 notice of intent to sell 148 shares of common stock, valued at approximately $20,039. The shares were acquired via restricted stock vesting on November 2, 2026, and the sale appears to cover a tax withholding obligation. The proposed sale is very small relative to the company's $11.5B market cap and the insider's recent selling history, making it a routine, low-impact event.
Key Facts
- Officer Robert F. Werner filed Form 144 to sell 148 shares of common stock.
- Estimated value of the proposed sale is $20,039.45.
- Shares were acquired on November 2, 2026 via restricted stock vesting.
- The filing notes the sale includes an amount necessary to cover a tax obligation from a vested equity award distribution.
- The insider has sold shares in each of the prior three months (August, September, October 2026) in amounts ranging from $14,248 to $279,925.
- The proposed sale represents approximately 0.0002% of Twist Bioscience's $11.5B market cap.
Financial Impact
Proceeds of approximately $20,039 from the sale of 148 shares, a negligible fraction of the company's $11.5B market cap.
Risk Factors
- Form 144 is an intent to sell; the actual sale may not occur.
- Insider selling patterns should be tracked over time for any escalation in volume.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-007695 |
| Document: 0001959173-26-007695-index.html | 0001959173-26-007695 |
| Document: 0001959173-26-007695.txt | 0001959173-26-007695 |
Track record
47 reports on TWST
8 of 11 bullish or bearish reports moved the stock their way by T+20. Best: +55.24% at T+60 after the Aug 3, 2026 report. 10 of 12 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 2/10 Entry $105.03 Now $105.04 +0.01% settles Dec 15
- Nov 16, 2026today 144 Neutral 2/10 Entry $105.16 Now $105.04 −0.11% settles Dec 15
- Nov 16, 2026today 144 Neutral 2/10 Entry $104.98 Now $105.04 +0.06% settles Dec 15
- Nov 16, 2026today 144 Neutral 2/10 Entry $105.61 Now $105.04 −0.54% settles Dec 15
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $104.03 Now $105.04 +0.98% settles Dec 15
- Nov 12, 20264d ago 8-K Bullish 6/10 Entry $114.22 Now $105.04 −8.04% settles Dec 11
- Nov 12, 20264d ago SC 13G/A Neutral 2/10 Entry $114.22 Now $105.04 −8.04% settles Dec 11
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $132.13 Now $105.04 −20.50% settles Dec 9
- Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $120.79 Now $105.04 −13.04% settles Dec 7
- Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $120.61 Now $105.04 −12.91% settles Dec 4
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers